Predictive value of endocervical curettage at cervical conization and provider practices in management of high-grade cervical dysplasia

Joyce N. Barlin, Robert E. Bristow, Anna M. Murillo, Marianna Zahurak, Emanuela Veras, Ritu Salani

Research output: Contribution to journalArticle

Abstract

OBJECTIVE: To determine the utility of endocervical curettage (ECC) at cervical conization for predicting residual or recurrent dysplasia and to evaluate differences in management between general gynecologists and gynecologic oncologists. STUDY DESIGN: From February 1999 to November 2007, 192 patients with high-grade dysplasia on conization were retrospectively identified. Data were analyzed for 54 patients who underwent repeat conization or hysterectomy to evaluate predictors of disease. Data for all patients were analyzed based on provider. RESULTS: Among patients who underwent secondary procedures, 68.5% (37/54) had residual or recurrent disease. Eighty-six percent of patients with a positive ECC had residual or recurrent disease compared to 48% of patients with a negative ECC (OR 6.91, CI 1.595-30.00, p = 0.01). Among all patients, 77% (148/192) were managed by a generalist, and 23% (44/192) by a gynecologic oncologist. Oncologists were significantly more likely to perform a hysterectomy (45.5% vs. 14.2%, OR 5.04, CI 2.38-10.69, p

Original languageEnglish (US)
Pages (from-to)129-133
Number of pages5
JournalJournal of Reproductive Medicine for the Obstetrician and Gynecologist
Volume55
Issue number3-4
StatePublished - Mar 2010
Externally publishedYes

Fingerprint

Uterine Cervical Dysplasia
Conization
Curettage
Practice Management
Hysterectomy

Keywords

  • Cervical neoplasia
  • Conization
  • Endocervical curettage
  • Papanicolaou smear

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Reproductive Medicine

Cite this

Predictive value of endocervical curettage at cervical conization and provider practices in management of high-grade cervical dysplasia. / Barlin, Joyce N.; Bristow, Robert E.; Murillo, Anna M.; Zahurak, Marianna; Veras, Emanuela; Salani, Ritu.

In: Journal of Reproductive Medicine for the Obstetrician and Gynecologist, Vol. 55, No. 3-4, 03.2010, p. 129-133.

Research output: Contribution to journalArticle

Barlin, Joyce N. ; Bristow, Robert E. ; Murillo, Anna M. ; Zahurak, Marianna ; Veras, Emanuela ; Salani, Ritu. / Predictive value of endocervical curettage at cervical conization and provider practices in management of high-grade cervical dysplasia. In: Journal of Reproductive Medicine for the Obstetrician and Gynecologist. 2010 ; Vol. 55, No. 3-4. pp. 129-133.
@article{cd3a743db3fc4c78ab9e305bf2ff55a7,
title = "Predictive value of endocervical curettage at cervical conization and provider practices in management of high-grade cervical dysplasia",
abstract = "OBJECTIVE: To determine the utility of endocervical curettage (ECC) at cervical conization for predicting residual or recurrent dysplasia and to evaluate differences in management between general gynecologists and gynecologic oncologists. STUDY DESIGN: From February 1999 to November 2007, 192 patients with high-grade dysplasia on conization were retrospectively identified. Data were analyzed for 54 patients who underwent repeat conization or hysterectomy to evaluate predictors of disease. Data for all patients were analyzed based on provider. RESULTS: Among patients who underwent secondary procedures, 68.5{\%} (37/54) had residual or recurrent disease. Eighty-six percent of patients with a positive ECC had residual or recurrent disease compared to 48{\%} of patients with a negative ECC (OR 6.91, CI 1.595-30.00, p = 0.01). Among all patients, 77{\%} (148/192) were managed by a generalist, and 23{\%} (44/192) by a gynecologic oncologist. Oncologists were significantly more likely to perform a hysterectomy (45.5{\%} vs. 14.2{\%}, OR 5.04, CI 2.38-10.69, p",
keywords = "Cervical neoplasia, Conization, Endocervical curettage, Papanicolaou smear",
author = "Barlin, {Joyce N.} and Bristow, {Robert E.} and Murillo, {Anna M.} and Marianna Zahurak and Emanuela Veras and Ritu Salani",
year = "2010",
month = "3",
language = "English (US)",
volume = "55",
pages = "129--133",
journal = "The Journal of reproductive medicine",
issn = "0024-7758",
publisher = "Donna Kessel",
number = "3-4",

}

TY - JOUR

T1 - Predictive value of endocervical curettage at cervical conization and provider practices in management of high-grade cervical dysplasia

AU - Barlin, Joyce N.

AU - Bristow, Robert E.

AU - Murillo, Anna M.

AU - Zahurak, Marianna

AU - Veras, Emanuela

AU - Salani, Ritu

PY - 2010/3

Y1 - 2010/3

N2 - OBJECTIVE: To determine the utility of endocervical curettage (ECC) at cervical conization for predicting residual or recurrent dysplasia and to evaluate differences in management between general gynecologists and gynecologic oncologists. STUDY DESIGN: From February 1999 to November 2007, 192 patients with high-grade dysplasia on conization were retrospectively identified. Data were analyzed for 54 patients who underwent repeat conization or hysterectomy to evaluate predictors of disease. Data for all patients were analyzed based on provider. RESULTS: Among patients who underwent secondary procedures, 68.5% (37/54) had residual or recurrent disease. Eighty-six percent of patients with a positive ECC had residual or recurrent disease compared to 48% of patients with a negative ECC (OR 6.91, CI 1.595-30.00, p = 0.01). Among all patients, 77% (148/192) were managed by a generalist, and 23% (44/192) by a gynecologic oncologist. Oncologists were significantly more likely to perform a hysterectomy (45.5% vs. 14.2%, OR 5.04, CI 2.38-10.69, p

AB - OBJECTIVE: To determine the utility of endocervical curettage (ECC) at cervical conization for predicting residual or recurrent dysplasia and to evaluate differences in management between general gynecologists and gynecologic oncologists. STUDY DESIGN: From February 1999 to November 2007, 192 patients with high-grade dysplasia on conization were retrospectively identified. Data were analyzed for 54 patients who underwent repeat conization or hysterectomy to evaluate predictors of disease. Data for all patients were analyzed based on provider. RESULTS: Among patients who underwent secondary procedures, 68.5% (37/54) had residual or recurrent disease. Eighty-six percent of patients with a positive ECC had residual or recurrent disease compared to 48% of patients with a negative ECC (OR 6.91, CI 1.595-30.00, p = 0.01). Among all patients, 77% (148/192) were managed by a generalist, and 23% (44/192) by a gynecologic oncologist. Oncologists were significantly more likely to perform a hysterectomy (45.5% vs. 14.2%, OR 5.04, CI 2.38-10.69, p

KW - Cervical neoplasia

KW - Conization

KW - Endocervical curettage

KW - Papanicolaou smear

UR - http://www.scopus.com/inward/record.url?scp=77953463359&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77953463359&partnerID=8YFLogxK

M3 - Article

C2 - 20506673

AN - SCOPUS:77953463359

VL - 55

SP - 129

EP - 133

JO - The Journal of reproductive medicine

JF - The Journal of reproductive medicine

SN - 0024-7758

IS - 3-4

ER -